AU2018438604A1 - Peptides having immunomodulatory properties - Google Patents

Peptides having immunomodulatory properties Download PDF

Info

Publication number
AU2018438604A1
AU2018438604A1 AU2018438604A AU2018438604A AU2018438604A1 AU 2018438604 A1 AU2018438604 A1 AU 2018438604A1 AU 2018438604 A AU2018438604 A AU 2018438604A AU 2018438604 A AU2018438604 A AU 2018438604A AU 2018438604 A1 AU2018438604 A1 AU 2018438604A1
Authority
AU
Australia
Prior art keywords
peptides
immunomodulatory properties
immunomodulatory
properties
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2018438604A
Inventor
Charles Garvin
Jesse Jaynes
Henry Wilfred Lopez
George R. Martin
Clayton Yates
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Riptide Bioscience Inc
Original Assignee
Riptide Bioscience Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Riptide Bioscience Inc filed Critical Riptide Bioscience Inc
Publication of AU2018438604A1 publication Critical patent/AU2018438604A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AU2018438604A 2018-08-29 2018-08-29 Peptides having immunomodulatory properties Pending AU2018438604A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2018/048632 WO2020046297A2 (en) 2018-08-29 2018-08-29 Peptides having immunomodulatory properties

Publications (1)

Publication Number Publication Date
AU2018438604A1 true AU2018438604A1 (en) 2021-03-18

Family

ID=69645844

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2018438604A Pending AU2018438604A1 (en) 2018-08-29 2018-08-29 Peptides having immunomodulatory properties

Country Status (8)

Country Link
EP (1) EP3844297A4 (en)
JP (2) JP2022511280A (en)
KR (1) KR20210052473A (en)
CN (1) CN113039194A (en)
AU (1) AU2018438604A1 (en)
CA (1) CA3110618A1 (en)
WO (1) WO2020046297A2 (en)
ZA (1) ZA202101327B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20190224275A1 (en) 2017-05-12 2019-07-25 Aurinia Pharmaceuticals Inc. Protocol for treatment of lupus nephritis
WO2022034523A1 (en) * 2020-08-13 2022-02-17 Immunitybio, Inc. Phagocytosis-inducing compounds and methods of use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020099008A1 (en) * 1999-04-26 2002-07-25 Daniel R. Twardzik Method for stimulating hematopoiesis using tgf-alpha
EP1741790A1 (en) * 2005-03-24 2007-01-10 DIGILAB BioVisioN GmbH Methods to identify and characterize prolyl oligopeptidases by using substrates and products thereof
US20120270770A1 (en) * 2010-08-03 2012-10-25 Jesse Michael Jaynes Anti-angiogenic peptides and their uses
JP6437467B2 (en) * 2013-03-14 2018-12-19 ガラパゴス・ナムローゼ・フェンノートシャップＧａｌａｐａｇｏｓ Ｎ．Ｖ． Molecular targets and compounds useful in the treatment of fibrotic diseases and methods for identifying them
CN107580502B (en) * 2014-10-14 2020-10-30 美国政府卫生与公众服务部 Peptide-based methods for treating pancreatic cancer
JP6964577B2 (en) * 2015-03-23 2021-11-10 リップタイド バイオサイエンス インコーポレイテッド Antibacterial peptide and its usage

Also Published As

Publication number Publication date
CA3110618A1 (en) 2020-03-05
CN113039194A (en) 2021-06-25
ZA202101327B (en) 2022-09-28
EP3844297A2 (en) 2021-07-07
JP2023145635A (en) 2023-10-11
JP2022511280A (en) 2022-01-31
EP3844297A4 (en) 2022-08-31
KR20210052473A (en) 2021-05-10
WO2020046297A2 (en) 2020-03-05

Similar Documents

Publication Publication Date Title
EP3723783A4 (en) Mitochondria-targeting peptides
EP3369741A4 (en) Novel peptide
EP3814330A4 (en) Immunomodulatory compounds
EP3733686A4 (en) Novel peptide
EP3746081A4 (en) Novel uses
EP3740228A4 (en) Peptides and uses thereof
EP3897128A4 (en) Antimicrobial peptides
EP3904701A4 (en) Clamp
ZA202101327B (en) Peptides having immunomodulatory properties
EP3802565A4 (en) Polypeptides
EP3700558A4 (en) Tau peptide immunogen constructs
EP3688037A4 (en) Immunomodulatory fusion proteins
EP3653063A4 (en) Peptide
EP3703188A4 (en) Airtight terminal
EP3866808A4 (en) Novel uses
AU2019350356A1 (en) Arginase1 polypeptides
EP3790394A4 (en) Aav-compatible laminin-linker polymerization proteins
EP3834079A4 (en) Multi-question multi-answer configuration
EP3725884A4 (en) Cell-membrane-permeable peptide
EP3760771A4 (en) Polyamide-610 multifilament
EP3898652A4 (en) Mitochondria-targeting peptides
EP3986914A4 (en) Constrained peptides
EP3978510A4 (en) Norovirus-binding peptide
EP3978511A4 (en) Norovirus-binding peptide
EP3792349A4 (en) Peptide macrocyclase